As announced in our "Notice Regarding Receipt of the Third-Party Committee’s Investigation Report" dated February 27, 2026, we received the Third-Party Committee’s Investigation Report on February 27, ...
Apellis Pharmaceuticals (NASDAQ:APLS) executives outlined a three-part strategy for the company at TD Cowen’s 46th Annual Healthcare Conference, emphasizing a “durable and resilient” SYFOVRE franchise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results